Friday, December 7, 2012

• Yum! to Exceed China Target and 4 Stock Analyses Demand Attentionat Wall St. Cheat Sheet (Fri, Dec 7)

Monday, December 3, 2012

• Upcoming AML Treatments - Which Company Will Fly?at Seeking Alpha (Mon, Dec 3)

Wednesday, November 28, 2012

• Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012Marketwired (Wed, Nov 28)

Tuesday, November 27, 2012

• 10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlookat CNBC (Tue, Nov 27)

Tuesday, November 20, 2012

• Sunesis to Present at the Piper Jaffray 24th Annual Healthcare ConferenceGlobeNewswire (Tue, Nov 20)

Wednesday, November 14, 2012

• Sunesis' CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)at Seeking Alpha (Wed, Nov 14)

Friday, November 9, 2012

• Monster Worldwide Remains Compelling and 4 Stock Analyses Not to Missat Wall St. Cheat Sheet (Fri, Nov 9)

Thursday, November 8, 2012

• Sunesis Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Nov 8)
• SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements aEDGAR Online (Thu, Nov 8)

Friday, October 26, 2012

• Why These 3 Biotech Stocks Are Winningat Motley Fool (Fri, Oct 26)

Monday, October 22, 2012

• FDA Considering Allowing Developers of Critical Drugs/Treatments to Conduct Smaller, Faster Clinical TrialsMarketwired (Mon, Oct 22)

Monday, October 8, 2012

• 2-Star Stocks Poised to Plunge: Sunesis Pharmaceuticals?at Motley Fool (Mon, Oct 8)

Sunday, October 7, 2012

• 4 Biotech Stocks With Large 2012 Gains Still Present Significant Upside - Revisitedat Seeking Alpha (Sun, Oct 7)

Friday, October 5, 2012

• Movers roundup: Informatica, SunesisAP (Fri, Oct 5)
• Sunesis Pharma rises on cancer drug study detailsAP (Fri, Oct 5)
• Sunesis Pharma Deemed Attractive and 4 Stock Analyses to See Nowat Wall St. Cheat Sheet (Fri, Oct 5)

Wednesday, October 3, 2012

• Hedge Funds Bought and Sold These Stocks Recentlyat Motley Fool (Wed, Oct 3)

Monday, October 1, 2012

• Assessing Peregrine & Seeking Upside In The Spaceat Seeking Alpha (Mon, Oct 1)

Friday, September 21, 2012

• Norfolk Southern Expected to Recover and 4 Must-See Stock Analysesat Wall St. Cheat Sheet (Fri, Sep 21)
• //C O R R E C T I O N//Myeloma Therapies, Hepatitis C Treatments, Colorectal Cancer Drugs, Phase III Trials for Hsp90 Inhibitor: Medical Breakthroughs are Powering Biotech Sector HigherWall Street Transcript (Fri, Sep 21)
• Colorectal Cancer Drug Regorafenib Receives Approval, Carfilzomib Approved for Myeloma Therapy, Hepatitis C Treatments, Phase III Trials for Hsp90 Inhibitor: Medical Breakthroughs are Powering Biotech Sector HigherWall Street Transcript (Fri, Sep 21)
• Parexel Partners with Salem State University and 4 Stocks Hitting 52-Week Highsat Wall St. Cheat Sheet (Fri, Sep 21)

Thursday, September 20, 2012

• SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Sep 20)

Wednesday, September 19, 2012

• Rigel Pharmaceuticals, Inc. (RIGL) President and Chief Operating Officer Raul R. Rodriguez: Wall Street Transcript InterviewWall Street Transcript (Wed, Sep 19)
• Biotech Stock Live Chat: Fall Previewat TheStreet (Wed, Sep 19)

Add SNSS News to My Yahoo!